Empower Clinics Inc : Tabula Rasa HealthCare Partners with Empower Clinics to Provide Clinical and Technical Call Center Services for COVID-19 and Influenza A/B At-Home Testing
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Tabula Rasa HealthCare Partners with Empower Clinics to Provide Clinical and Technical Call Center Services for COVID-19 and Influenza A/B At-Home Testing
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
MOORESTOWN, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE)
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), today announced CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; Chief Sales Officer, Kevin Boesen; and Chief Financial Officer, Brian W. Adams, will participate in the 39
th Annual J.P. Morgan Healthcare Conference to be held virtually January 11-14, 2021.
The TRHC presentation is scheduled for Thursday, January 14, 2021 at 4:30 p.m. EST. An audio replay of the presentation will be available at https://ir.tabularasahealthcare.com/.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) provides patient medication safety solutions empowering pharmacists and prescribers to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. Utilizing its proprietary medication decision science technology, MedWise™, TRHC improves
Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare’s DoseMeRx Integration
Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare’s DoseMeRx Integration
Wolters Kluwer, Health, a global provider of trusted clinical technology and evidence-based solutions, has announced the integration of DoseMeRx„¢, a Tabula Rasa Healthcare precision dosing solution, with Sentri7s Antimicrobial Stewardship (AMS) solution. With a single click, pharmacists can review patient-specific parenteral vancomycin dose recommendations calculated automatically using key clinical data such as patient weight, laboratory values, creatinine levels and drug administration times. Dosing and monitoring of vancomycin can be complex, requiring patient data and laboratory results to individualize the dose for each patient, said Charles Cornish, Executive Vice President, Hospitals Business Unit, TRHC. By integrating our precision dosing platform with Wolters Kluwers Sentri7 solution